Mark Elliott Boulding - 05 Jan 2023 Form 4 Insider Report for PTC THERAPEUTICS, INC. (PTCT)

Role: EXEC. VP AND CLO
Signature: /s/ Avraham S. Adler, Attorney-in-Fact
Issuer symbol: PTCT
Transactions as of: 05 Jan 2023
Net transactions value: $0
Form type: 4
Filing time: 09 Jan 2023, 15:56:46 UTC
Previous filing: 19 Oct 2022
Next filing: 11 Jan 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PTCT	Common Stock	Award	$0	+17,000	+28%	$0.000000	78,110	05 Jan 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PTCT	Stock Option (Right to Buy)	Award	$0	+36,250		$0.000000	36,250	05 Jan 2023	Common Stock	36,250	$39.42	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units granted on January 5, 2023 that vest in four equal installments over four years, commencing on January 5, 2024.
F2	This option was granted on January 5, 2023, and vests over four years, with 25% of the shares underlying the option vesting on January 5, 2024, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 5, 2024.